Antiviral agents
Antiviral agents are a class of drugs for treatment of viral infections. Among the human viruses or the diseases they produce for which we need useful or improved drugs or vaccines, we may list the following: HIV-1 (AIDS), cytomegalovirus, Epstein-Barr virus, HSV- 1, HSV-2, varicella virus, influenza A, influenza B, enterovirus, hepatitis A, hepatitis B, adenovirus, common cold, bronchiolitis, croup, dengue, poliomyelitis, measles, rabies, warts, chickenpox, mumps, and rubella[1].
[1] WH Prusoff et al. Approaches to antiviral drug development. Yale J Biol Med. 1989 Mar-Apr; 62(2): 215–225.
| Axon ID | Name | Description | From price | |
|---|---|---|---|---|
| 3416 | AA147 | Endoplasmic reticulum (ER) proteostasis regulator | €80.00 | |
| 3384 | Acyclovir | Highly selective inhibitor of herpes virus DNA polymerase | €60.00 | |
| 1571 | AG 7088 | HRV3C protease inhibitor | €60.00 | |
| 3549 | Aloperine | Potent multifunctional anti-tumor agent | €50.00 | |
| 3465 | Amenamevir | Potent helicase-primase inhibitor | €130.00 | |
| 3140 | Arbidol hydrochloride | Broad-spectrum antiviral agent | €60.00 | |
| 2266 | BAY 57-1293 | Potent helicase-primase inhibitor, effective against herpes simplex virus (HSV) infections | €80.00 | |
| 1441 | BMS 232632 | Protease inhibitor | €80.00 | |
| 3360 | CBS1117 | Virus entry inhibitor | €110.00 | |
| 2665 | Cenicriviroc | Oral CCR5-antagonist for treatment of HIV infection | €150.00 | |
| 2455 | CU-T12-9 | Selective TLR1/TLR2 agonist that facilitates the TLR1/2 complex formation | €120.00 | |
| 2093 | Daclatasvir dihydrochloride | Hepatitis C virus (HCV) NS5A protein inhibitor | €70.00 | |
| 1669 | Danoprevir | HCV NS3/4A serine protease inhibitor | €80.00 | |
| 1815 | Delavirdine | NNRT inhibitor (HIV-1) | €90.00 | |
| 3141 | DHQZ 36 | Potent retrograde trafficking inhibitor | €120.00 | |